This inventor holds 19 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 11 EPO patents, primarily in Anticancer Compounds. Top assignees: Bristol-Myers Squibb Compnay, Bristol-Myers Squibb Pharma Company. Active years: 2005-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
18 out of 3,745 
1 out of 234 
Years Active: 2005-2018
Areas of Expertise:
Title: The Innovative Contributions of George V Delucca
Introduction
George V Delucca, a prominent inventor based in Pennington, NJ, has made significant contributions to the field of pharmaceutical chemistry with a remarkable portfolio of 19 patents. His innovative work primarily focuses on developing compounds that serve as potential treatments for various disorders, showcasing his dedication to advancing medical science and improving healthcare outcomes.
Latest Patents
Among Delucca's latest patents, the invention of tricyclic compounds as anticancer agents stands out. This patent is directed towards novel tricyclic compounds, which are essential in creating pharmaceutically acceptable compositions aimed at treating various disorders. Additionally, his patent for substituted tetrahydrocarbazole and carbazole carboxamide compounds unveils new compounds represented by specific formulas. These compounds are designed to act as inhibitors of Bruton's tyrosine kinase (Btk) and hold promise in treating autoimmune diseases and vascular disorders. Both patents demonstrate Delucca’s commitment to leveraging chemistry in tackling complex health issues.
Career Highlights
Delucca has honed his expertise through a notable career with esteemed organizations, including Bristol-Myers Squibb Company and Bristol-Myers Squibb Pharma Company. His work in these companies has facilitated the realization of groundbreaking pharmaceutical innovations that have the potential to change the way certain diseases are treated.
Collaborations
His collaborative efforts with fellow scientists, such as Ashvinikumar V Gavai and Douglas G Batt, underscore the importance of teamwork in the pursuit of innovation. Together, they have paved the way for new discoveries in pharmaceutical development, contributing to Delucca’s extensive patent portfolio.
Conclusion
In summary, George V Delucca exemplifies the spirit of innovation in the pharmaceutical industry. His extensive patent work not only highlights his scientific ingenuity but also his commitment to improving patient care through advanced therapeutic options. As he continues to push boundaries in pharmaceutical chemistry, his contributions remain influential in the ongoing quest for effective medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile